title: Urinary adverse effects of pelvic radiotherapy.
abstract: OBJECTIVE
  Radiation is an integral part of the treatment of many pelvic tumors. The cellular death induced by radiotherapy (RT) benefits cancer control but can also result in adverse effects (AEs) on the organ being treated or those adjacent to it. RT for cancers of the pelvis (bladder, prostate, rectum, uterus or cervix) can result in AEs in the urinary tract. While the acute urinary AEs of pelvic RT are well described, late AEs are less well characterized. The burden of treatment for late AEs may be large given the prevalence of tumors in the pelvis and the high utilization of RT to treat them.
  
  
  METHODS
  For prostate cancer, grade 1 and 2 urinary AEs following external beam radiation therapy (EBRT) are reported to occur in 20-43% and 7-19%, respectively, with a follow up of 10 years. Three-year cumulative risk for grade ≥2 urinary AEs is 28-30%. Following brachytherapy (BT), rates of urinary AEs at 5 years are reported to be 36%, 24%, 6.2% and 0.1% for Radiation Therapy Oncology Group (RTOG) grade 1, 2, 3, and 4, respectively. For bladder cancer, with a median follow-up of 5 years, 7-12% of patients who receive RT experience urinary AEs of grade 3 or more. For cervical cancer, there remains a 0.25% per year risk of severe AEs for at least 25 years following RT, and ureteral stricture is a well-described AE. For endometrial cancer, severe urinary AEs are rare, but at 13 years of follow up, patients report a significantly worse quality of life with respect to urinary function. In rectal cancer, preoperative RT has a lower risk of AEs than postoperative RT, and few urinary AEs are reported in the literature.
  
  
  CONCLUSIONS
  Urinary AEs can manifest long after RT, and there is a paucity of studies describing rates of these long-term AEs. It is important that the possible complications of RT are recognized by providers and properly communicated to patients so that they are able to make informed decisions about their cancer treatment.
authors.affiliation: Department of Urology, University of Minnesota School of Medicine, Minneapolis, MN, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Liberman
authors.affiliation: Department of Urology, University of Minnesota School of Medicine, Minneapolis, MN, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Mehus
authors.affiliation: Department of Urology, University of Minnesota School of Medicine, Minneapolis, MN, USA.
authors.forename: Sean P
authors.initials: SP
authors.lastname: Elliott
keywords: Pelvic radiotherapy; adverse effects (AEs); urinary toxicity; urinary tract
references.citation: Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1261-6
references.pmid: 10889379
references.citation: BJU Int. 2008 Nov;102(9 Pt B):1345-53
references.pmid: 19035903
references.citation: CMAJ. 2001 Apr 3;164(7):975-81
references.pmid: 11314451
references.citation: Am J Obstet Gynecol. 2007 Nov;197(5):503.e1-6
references.pmid: 17980189
references.citation: Ann Oncol. 2011 Sep;22 Suppl 6:vi35-9
references.pmid: 21908501
references.citation: Gynecol Oncol. 1989 May;33(2):237-40
references.pmid: 2703184
references.citation: J Urol. 1995 Dec;154(6):2144-8
references.pmid: 7500479
references.citation: Brachytherapy. 2007 Oct-Dec;6(4):258-66
references.pmid: 17991623
references.citation: N Engl J Med. 2012 Apr 19;366(16):1477-88
references.pmid: 22512481
references.citation: Radiother Oncol. 1998 Dec;49(3):223-32
references.pmid: 10075255
references.citation: J Clin Oncol. 2002 Jul 15;20(14):3061-71
references.pmid: 12118019
references.citation: Cancer. 1999 Jun 1;85(11):2460-8
references.pmid: 10357419
references.citation: J Clin Oncol. 2009 Sep 1;27(25):4055-61
references.pmid: 19636019
references.citation: Radiother Oncol. 1997 Feb;42(2):143-53
references.pmid: 9106923
references.citation: J Clin Oncol. 2006 May 1;24(13):1990-6
references.pmid: 16648499
references.citation: Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):65-70
references.pmid: 17189063
references.citation: Lancet. 2009 Jul 18;374(9685):239-49
references.pmid: 19520422
references.citation: Urology. 2007 Sep;70(3):548-53
references.pmid: 17905113
references.citation: Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):453-60
references.pmid: 11872292
references.citation: J Urol. 1997 Sep;158(3 Pt 1):814-7
references.pmid: 9258089
references.citation: Nat Clin Pract Oncol. 2008 Aug;5(8):444-54
references.pmid: 18577983
references.citation: Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34
references.pmid: 15752881
references.citation: Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1431-40
references.pmid: 19211196
references.citation: Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1100-9
references.pmid: 17967304
references.citation: Br J Surg. 2006 Dec;93(12):1519-25
references.pmid: 17054311
references.citation: Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):496-501
references.pmid: 20350785
references.citation: Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):685-91
references.pmid: 18718725
references.citation: Lancet. 2010 Mar 6;375(9717):816-23
references.pmid: 20206777
references.citation: Strahlenther Onkol. 2013 Jul;189(7):535-40
references.pmid: 23703404
references.citation: Radiother Oncol. 2004 Aug;72(2):139-45
references.pmid: 15297133
references.citation: BJU Int. 2013 Jul;112(1):13-25
references.pmid: 23356411
references.citation: Cancer. 2004 Nov 1;101(9):2011-9
references.pmid: 15452835
references.citation: Int J Clin Oncol. 2006 Aug;11(4):320-5
references.pmid: 16937307
references.citation: Eur Urol. 2012 Jan;61(1):112-27
references.pmid: 22001105
references.citation: World J Urol. 2008 Oct;26(5):447-56
references.pmid: 18777126
references.citation: J Endourol. 2009 Mar;23(3):457-61
references.pmid: 19250027
references.citation: Lancet. 2009 Jan 10;373(9658):137-46
references.pmid: 19070891
references.citation: Cancer. 1995 Feb 1;75(3):836-43
references.pmid: 7828135
references.citation: Actas Urol Esp. 2009 Feb;33(2):113-26
references.pmid: 19418833
references.citation: Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):319-27
references.pmid: 9607347
references.citation: Radiat Med. 2000 Jul-Aug;18(4):261-5
references.pmid: 11247004
references.citation: J Clin Oncol. 2006 Nov 20;24(33):5298-304
references.pmid: 17114664
references.citation: Int J Urol. 2012 May;19(5):388-401
references.pmid: 22409269
references.citation: Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1005-11
references.pmid: 19540058
references.citation: Lancet. 2001 Sep 8;358(9284):781-6
references.pmid: 11564482
references.citation: Int Urol Nephrol. 2002;34(1):31-5
references.pmid: 12549636
references.citation: Eur Urol. 2013 Jan;63(1):45-57
references.pmid: 22917985
references.citation: J Clin Oncol. 2011 May 1;29(13):1692-700
references.pmid: 21444867
references.citation: J Clin Oncol. 2010 Nov 1;28(31):4687-96
references.pmid: 20921463
references.citation: Eur Urol. 2012 Apr;61(4):705-11
references.pmid: 22101114
references.citation: Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1185-91
references.pmid: 10725630
references.citation: Radiother Oncol. 2004 Oct;73(1):33-8
references.pmid: 15465143
references.citation: N Engl J Med. 1997 Apr 3;336(14):980-7
references.pmid: 9091798
references.citation: Cancer J. 2007 May-Jun;13(3):204-9
references.pmid: 17620771
references.citation: J Clin Oncol. 1999 Feb;17(2):517-22
references.pmid: 10080594
references.citation: Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1017-24
references.pmid: 20932687
references.citation: Brachytherapy. 2006 Jan-Mar;5(1):9-13
references.pmid: 16563992
references.citation: Radiother Oncol. 2007 Jan;82(1):46-9
references.pmid: 17161481
references.citation: N Engl J Med. 2004 Oct 21;351(17):1731-40
references.pmid: 15496622
references.citation: Am J Clin Oncol. 2010 Apr;33(2):168-72
references.pmid: 19745696
references.citation: Clin Oncol (R Coll Radiol). 2008 Jun;20(5):358-64
references.pmid: 18395427
references.citation: Eur J Cancer. 2009 Nov;45(16):2825-34
references.pmid: 19682889
references.citation: Urology. 2012 Jun;79(6):1402-5
references.pmid: 22521189
references.citation: Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1289-300
references.pmid: 7635768
references.citation: Urol Clin North Am. 2013 Aug;40(3):407-19
references.pmid: 23905939
references.citation: Onkologie. 2003 Aug;26(4):334-40
references.pmid: 12972698
references.citation: Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1257-80
references.pmid: 7713787
references.citation: Int J Radiat Oncol Biol Phys. 1991 Sep;21(4):935-9
references.pmid: 1917622
references.citation: Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105
references.pmid: 12128107
references.citation: Clin Oncol (R Coll Radiol). 2009 Oct;21(8):598-609
references.pmid: 19632819
references.citation: J Urol. 2003 Nov;170(5):1772-6
references.pmid: 14532773
references.citation: N Engl J Med. 2008 Mar 20;358(12):1250-61
references.pmid: 18354103
references.citation: Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308
references.pmid: 16029785
references.citation: Int J Cancer. 2005 Aug 20;116(2):291-6
references.pmid: 15800919
references.citation: Radiother Oncol. 1997 Feb;42(2):99-106
references.pmid: 9106919
references.citation: J Urol. 2005 Mar;173(3):808-12
references.pmid: 15711274
references.citation: JAMA. 2005 Sep 14;294(10):1233-9
references.pmid: 16160131
references.citation: Gynecol Oncol. 2004 Mar;92(3):744-51
references.pmid: 14984936
references.citation: Radiother Oncol. 2002 Feb;62(2):215-25
references.pmid: 11937249
references.citation: Lancet. 2000 Apr 22;355(9213):1404-11
references.pmid: 10791524
references.citation: Ann Oncol. 2012 Oct;23 Suppl 7:vii27-32
references.pmid: 22997451
references.citation: Cancer. 2001 Aug 15;92(4):896-902
references.pmid: 11550163
references.citation: Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1023-32
references.pmid: 19111402
references.citation: J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67
references.pmid: 15367568
references.citation: Radiother Oncol. 2011 Jul;100(1):116-23
references.pmid: 21821305
references.citation: J Nucl Med Technol. 2001 Jun;29(2):67-73; test 76-7
references.pmid: 11376098
references.citation: J Clin Oncol. 1997 Mar;15(3):1022-9
references.pmid: 9060542
references.citation: BJU Int. 2012 Aug;110(3):304-25
references.pmid: 22340079
references.citation: Cancer. 2007 May 1;109(9):1756-62
references.pmid: 17366596
references.citation: Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):142-8
references.pmid: 22014952
references.citation: J Natl Cancer Inst. 2012 Nov 7;104(21):1625-34
references.pmid: 22962693
references.citation: J Urol. 2011 May;185(5):1761-5
references.pmid: 21420123
references.citation: Radiother Oncol. 2009 Nov;93(2):153-67
references.pmid: 19765845
references.citation: Urology. 2009 Sep;74(3):601-5
references.pmid: 19589580
references.citation: Br J Cancer. 2004 Jun 1;90(11):2106-11
references.pmid: 15150587
references.citation: Radiother Oncol. 2007 Aug;84(2):164-70
references.pmid: 17706308
references.citation: Cancer. 2007 Jun 1;109(11):2239-47
references.pmid: 17455209
references.citation: Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):714-20
references.pmid: 22763030
references.citation: Gynecol Oncol. 1998 Nov;71(2):196-203
references.pmid: 9826460